Bharat Book Bureau Provides the Trending Market Research Report on “Global Peripheral Neuropathy Treatment Market Report and Forecast 2023-2031” under the Life Sciences Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence, and Market reports.
The global Peripheral Neuropathy Treatment Market reached a value of about USD 737 million in 2022 and is expected to grow at a CAGR of 3.7% during the forecast period of 2023-2031. With the rising prevalence of chronic diseases, which increase the risk of peripheral neuropathy in chronic disease patients, the market is expected to reach USD 1022 million by 2031.
Peripheral neuropathy Treatment Market: Introduction
The peripheral neuropathy treatment market refers to the market for the diagnosis and treatment of peripheral neuropathy, which is a condition that affects the nerves outside of the brain and spinal cord, leading to symptoms such as pain, numbness, and tingling. The condition can be caused by a variety of factors, including diabetes, alcoholism, and autoimmune disorders, and can have a significant impact on the quality of life of affected individuals.
The global peripheral neuropathy treatment market is highly competitive, with key players focusing on research and development activities to develop innovative products and strengthen their market position. The market is characterized by the presence of both global and regional players. The increasing prevalence of peripheral neuropathy, the growing demand for effective treatment options, and the availability of advanced healthcare infrastructure in developed countries are expected to drive the growth of the market during the forecast period.
Peripheral Neuropathy Epidemiology
Peripheral neuropathy is a common condition that affects millions of people worldwide, with the prevalence of the condition increasing with age. The exact cause of peripheral neuropathy is unclear, but it is believed to be a combination of genetic and environmental factors, such as diabetes, alcoholism, and autoimmune disorders. According to a study published in the Journal of the Peripheral Nervous System, the prevalence of peripheral neuropathy in the United States is estimated to be between 2.4% and 7.8%, with the highest prevalence observed in individuals aged 60 years or older.
The prevalence of peripheral neuropathy is expected to increase in the coming years due to the aging population and the rising incidence of diabetes and other chronic diseases. These factors are expected to drive the demand for peripheral neuropathy treatment in the coming years.
Peripheral Neuropathy Treatment Market Segmentations
The market can be categorised into type, treatment method, diagnosis, end user, treatment channel, and major region.
Market Breakup by Type
•Diabetic Peripheral Neuropathy
•Chemotherapy-Induced Peripheral Neuropathy
•Idiopathic Peripheral Neuropathy
•HIV/AIDS Associated Peripheral Neuropathy
Market Breakup by Treatment Method
•Pharmacological Therapies
ØPain Relievers
ØAnti-Seizure Medications
ØAnti-Depressants
•Non-Pharmacological Therapies
ØTranscutaneous Electrical Nerve Stimulation
ØPlasma Exchange
ØOthers
•Others
Peripheral Neuropathy Treatment Market Breakup by End User
•Hospitals and Clinics
•Retail Pharmacy
•Online Pharmacy
Market Breakup by Treatment Channel
•Public
•Private
Peripheral neuropathy Treatment Market Breakup by Region
•North America
ØUnited States of America
ØCanada
•Europe
ØUnited Kingdom
ØGermany
ØFrance
ØItaly
ØOthers
•Asia Pacific
ØChina
ØJapan
ØIndia
ØASEAN
ØAustralia
ØOthers
•Latin America
ØBrazil
ØArgentina
ØMexico
ØOthers
•Middle East and Africa
ØSaudi Arabia
ØUnited Arab Emirates
ØNigeria
ØSouth Africa
ØOthers
Peripheral neuropathy Treatment Market Scenario
The global peripheral neuropathy treatment market is expected to witness significant growth during the forecast period of 2023-2031. The market is driven by factors such as the increasing prevalence of peripheral neuropathy, the growing demand for effective treatment options, and the availability of advanced healthcare infrastructure in developed countries. Additionally, the rising incidence of chronic diseases such as diabetes and cancer, which are leading causes of peripheral neuropathy, is also contributing to the growth of the market.
North America dominates the peripheral neuropathy treatment market, followed by Europe and the Asia Pacific. The market in North America is driven by the high prevalence of peripheral neuropathy and the availability of advanced healthcare infrastructure. The market in Europe is also expected to grow significantly, with key players focusing on research and development activities to develop innovative products. The market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period, owing to the increasing awareness about peripheral neuropathy and the rising healthcare expenditure in the region.
Key Players in the Global Peripheral Neuropathy Treatment Market
The report gives an in-depth analysis of the key players involved in the peripheral neuropathy treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
•Abbott Laboratories
•Bristol Myers Squibb Co
•Novartis AG
•Eli Lilly and Company
•Pfizer Inc.
•GlaxoSmithKline Plc
•Merck and Co. Inc.
•F. Hoffmann-La Roche Ltd
•Cipla Ltd.
•Lupin Ltd
•Dr. Reddy’s Laboratories
•RxFunction, Inc.
Browse our full report with Table of Content:
About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,00,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian